Zobrazeno 1 - 10
of 1 373
pro vyhledávání: '"acute lymphoblastic leukemia (all)"'
Autor:
Andrea Ghelli Luserna di Rorà, Mouna Jandoubi, Antonella Padella, Anna Ferrari, Andrea Marranci, Cristina Mazzotti, Francesco Olimpico, Martina Ghetti, Lorenzo Ledda, Maria Teresa Bochicchio, Matteo Paganelli, Michele Zanoni, Alessandro Cafaro, Chiara Servili, Sara Galimberti, Michele Gottardi, Michela Rondoni, Mauro Endri, Daniela Onofrillo, Ernesta Audisio, Giovanni Marconi, Giorgia Simonetti, Giovanni Martinelli
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-18 (2024)
Abstract Background The introduction of antibody–drug conjugates represents a significant advancement in targeted therapy of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Our study aims to investigate the role of the DNA dama
Externí odkaz:
https://doaj.org/article/1b46b4b2fe0042f6bbd4a552ab12b9e6
Autor:
Somayeh Yazdanparast, Davood Bashash, Amirsalar Nikkhah Bahrami, Mohammad Ghorbani, Mehrdad Izadirad, Mehdi Bakhtiyaridovvombaygi, Ahmad Gharehbaghian
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 27, Iss 7, Pp 801-812 (2024)
Objective(s): Until recently, a conventional chemotherapy regimen for Acute lymphoblastic leukemia (ALL) is considered an efficient therapeutic method in children. However, suboptimal long-term survival rates in adults, disease relapse, and drug-indu
Externí odkaz:
https://doaj.org/article/baed8d007dc84414b5017077ef41690e
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Objective We aim to evaluate the efficacy and safety of blinatumomab for the treatment of post-transplant relapse patients with acute lymphoblastic leukemia (ALL).Methods The search was conducted using several databases including the PubMed, Cochrane
Externí odkaz:
https://doaj.org/article/e834230f9a604cb3a4d0aa2dadd92926
Publikováno v:
PeerJ, Vol 12, p e18296 (2024)
Background Childhood acute lymphoblastic leukemia (ALL) is a common pediatric cancer. The heterogeneous characterization of B cells in ALL progression poses new challenges to researchers. We used single-cell sequencing to explore the critical role of
Externí odkaz:
https://doaj.org/article/9a775ed76fc545a0851b727e820890df
Autor:
Alex Hoover, Dave Watson, Paige Reimche, Lynn Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M. Turcotte
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-4 (2024)
Abstract Objective Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy and among the most common malignancies in young adults and requires a unique pattern of healthcare utilization including an acute/emergent presentation and
Externí odkaz:
https://doaj.org/article/96c9a53faabe47528ac86a6ace030474
Autor:
Alessandro Laganà, Matteo Totaro, Maria Laura Bisegna, Loredana Elia, Stefania Intoppa, marco Beldinanzi, Mabel Matarazzo, Mariangela di Trani, Alessandro Costa, Raffaele Maglione, Biancamaria Mandelli, Sabina Chiaretti, Maurizio Martelli, Maria Stefania De Propris
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
Background: B-lineage acute lymphoblastic leukemias (B-ALL) harboring the t(9;22)(q34;q11)/BCR::ABL1rearrangement, represent a category with previously dismal prognosis whose management and outcome dramatically changed thanks to the use of tyrosine k
Externí odkaz:
https://doaj.org/article/e29c4b9f93a64e38ba922c03229d13d1
Autor:
Sameh Awwad, Rawan Abu Alnasr, Fahad Almanjomi, Murtada Al Sultan, Jude Howaidi, Mohammed Almotairi, Issam AlFayyad
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 9, Iss 1, Pp 54-62 (2024)
Background: Leukemia is the most prevalent type of cancer affecting children, representing approximately 35% of cancer diagnoses in Saudi Arabia. Notably, significant improvement in the overall survival and cure rates for pediatrics with acute lympho
Externí odkaz:
https://doaj.org/article/0bb6c15c9ef74e5e89e08870a316686e
Publikováno v:
IEEE Access, Vol 12, Pp 29252-29268 (2024)
Acute lymphoblastic leukemia (ALL), one of the prevalent types of carcinogenic disease, has been seen a deadly illness exposing numerous patients across the world to potential threats of lives. It impacts both adults and children providing a narrow r
Externí odkaz:
https://doaj.org/article/1fa96396b7164b058d6076175a233041
Autor:
Hisham S. Abou-Auda, Fatimah Alotaibi, Sary Alsanea, Abdulrahman Alwhaibi, Mohammed M. Almutairi, Ziyad Alrabiah, Abdullah Alsultan, Majed Al Jeraisy
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 5, Pp 102060- (2024)
Understanding the pharmacokinetics of gentamicin is essential in special populations, such as pediatric patients with acute lymphoblastic leukemia (ALL), in light of previous studies indicating that ALL patients have a lower volume of distribution th
Externí odkaz:
https://doaj.org/article/990726c480da470ea9657ed7812e2c82
Autor:
Chengxin Luan, Haixia Wang, Junjie Zhou, Zhangbiao Long, Xin Chen, Xiaowen Chen, Jing Ni, Zhengqi Huang, Ruixiang Xia, Jian Ge
Publikováno v:
Biomedical Technology, Vol 3, Iss , Pp 59-65 (2023)
Background: Tocilizumab is a well-practiced strategy to manage cytokine release syndrome (CRS) after chimeric antigen receptor T cell (CAR-T) therapy. However, varied efficiency in CRS mitigation by tocilizumab has been reported to highlight affectin
Externí odkaz:
https://doaj.org/article/318c40d0a0ac4162bd72a6440006f514